A detailed history of Bank Of Nova Scotia transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bank Of Nova Scotia holds 729,614 shares of GILD stock, worth $68.5 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
729,614
Previous 357,472 104.1%
Holding current value
$68.5 Million
Previous $24.5 Million 149.35%
% of portfolio
0.13%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$66.59 - $83.99 $24.8 Million - $31.3 Million
372,142 Added 104.1%
729,614 $61.2 Million
Q2 2024

Aug 14, 2024

SELL
$63.15 - $72.88 $71.4 Million - $82.4 Million
-1,130,952 Reduced 75.98%
357,472 $24.5 Million
Q1 2024

May 14, 2024

BUY
$71.58 - $87.29 $75.9 Million - $92.6 Million
1,060,673 Added 247.97%
1,488,424 $109 Million
Q4 2023

Feb 12, 2024

BUY
$73.27 - $83.09 $9.57 Million - $10.8 Million
130,552 Added 43.93%
427,751 $34.7 Million
Q3 2023

Nov 14, 2023

SELL
$73.94 - $80.67 $24.7 Million - $26.9 Million
-334,060 Reduced 52.92%
297,199 $22.3 Million
Q2 2023

Aug 03, 2023

BUY
$76.01 - $86.7 $40.8 Million - $46.5 Million
536,616 Added 566.99%
631,259 $48.7 Million
Q1 2023

May 11, 2023

SELL
$77.31 - $88.08 $17.5 Million - $20 Million
-226,933 Reduced 70.57%
94,643 $7.85 Million
Q4 2022

Feb 09, 2023

SELL
$62.32 - $89.47 $43.3 Million - $62.2 Million
-695,005 Reduced 68.37%
321,576 $27.6 Million
Q3 2022

Nov 10, 2022

SELL
$59.54 - $68.01 $8.54 Million - $9.76 Million
-143,437 Reduced 12.37%
1,016,581 $62.7 Million
Q2 2022

Aug 05, 2022

SELL
$57.72 - $65.01 $26 Million - $29.2 Million
-449,710 Reduced 27.94%
1,160,018 $71.7 Million
Q1 2022

May 09, 2022

BUY
$57.92 - $72.58 $27.6 Million - $34.6 Million
476,057 Added 41.99%
1,609,728 $95.7 Million
Q4 2021

Feb 11, 2022

BUY
$64.88 - $73.64 $18 Million - $20.5 Million
277,791 Added 32.46%
1,133,671 $82.7 Million
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $43.1 Million - $46.5 Million
637,081 Added 291.17%
855,880 $59.8 Million
Q2 2021

Aug 12, 2021

BUY
$63.47 - $69.35 $13.9 Million - $15.2 Million
218,799 New
218,799 $15.1 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Bank Of Nova Scotia Portfolio

Follow Bank Of Nova Scotia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.